Evommune, Inc. Common Stock (EVMN)
SG&A Expense Growth
27.85%
Quarterly · Period ending:
EVMN SG&A Expense Growth
Latest reported27.85%period ending
Latest reported27.85%period ending
EVMN Quarterly SG&A Growth (QoQ) (0.00% → 27.85%)
Latest values, visible window
High-resolution chart · PNG
EVMN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 27.8523% | |
| -28.7555% | |
| 152.4532% | |
| 9.9225% | |
| 1.9131% | |
| -3.868% | |
| 6.1183% | |
| 15.865% | |
| 9.858% | |
| 0% |